Rare diseases
Investigational molecules
Locations
Wittland 13, Hasseldieksdamm, 24109 Kiel, Germany
GALENpharma GmbH focuses on clinical research in plaque psoriasis, with interest in the management of chronic stable plaque-type disease and its visible inflammatory features.
The sponsor’s research activity is centred on assessing treatment effects on erythema, induration, and scaling in cutaneous inflammatory disease.
GALENpharma GmbH runs clinical trials in conditions such as Psoriasis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
